Medroxyprogesterone Acetate Tablet
Pfizer Inc.
Open FDA's page for this record- Discontinued date
- 11/19/2026
- Update type
- New
- Initial posting date
- 11/19/2026
- Package NDC
- 0009-0287-01
- Generic name
- Medroxyprogesterone Acetate Tablet
- Contact info
- 800-533-4535
- Related info
- Discontinuation of the manufacture of the drug
- Update date
- 11/19/2026
- Dosage form
- Tablet
- Presentation
- Provera, Tablet, 5 mg (NDC 0009-0287-01)
- Company name
- Pfizer Inc.
- Status
- To Be Discontinued
- Therapeutic category
- Urology
- Harmonized identifiers (openFDA)
- Application number
- NDA011839
- Brand name
- PROVERA
- Generic name
- MEDROXYPROGESTERONE ACETATE
- Manufacturer name
- Pharmacia & Upjohn Company LLC
- Product NDC
- 0009-0287, 0009-0065, 0009-0051
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- MEDROXYPROGESTERONE ACETATE
- RxCUI
- 1000114, 1000124, 1000135, 1000139, 1000141, 1000145
- SPL ID
- ebcdf2fb-760c-4a9a-80a1-a0c6b21a891a
- SPL set ID
- a586be28-96af-4fed-a13f-9b94fd4c7405
- Package NDC
- 0009-0065-01, 0009-0287-01, 0009-0051-01
- UNII
- C2QI4IOI2G
